Patients carrying mutations in DNAH1 and DNAH2 typically lack PCD symptoms (Khan et al., 2021), although a study suggested the potential contribution of the DNAH1 p.Lys1154Gln mutation to PCD (Imtiaz et al., 2015). This evidence concerns the gene DNAH1 and primary ciliary dyskinesia.